$HQY
HEALTHEQUITY, INC. Stock $hqy

$hqy Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-K Financial Statement

#000142833621000011 Filed on March 31, 2021

Income Statement

Concept	2021 Q1	2020 Q1	2019 Q1
Revenue	$188.2M	$201.2M	$75.78M
YoY Change	-6.46%	165.52%	25.38%
Cost Of Revenue	$87.30M	$87.52M	$31.33M
YoY Change	-0.25%	179.33%	8.83%
Gross Profit	$100.9M	$113.7M	$44.45M
YoY Change	-11.24%	155.78%	40.44%
Gross Profit Margin	53.61%	56.5%	58.65%
Selling, General & Admin	$36.40M	$37.30M	$16.40M
YoY Change	-2.41%	127.44%	15.49%
% of Gross Profit	36.08%	32.81%	36.9%
Research & Development	$32.30M	$31.50M	$10.00M
YoY Change	2.54%	215.0%	33.33%
% of Gross Profit	32.01%	27.71%	22.5%
Depreciation & Amortization	$30.40M	$26.60M	$4.700M
YoY Change	14.29%	465.96%	-4.08%
% of Gross Profit	30.13%	23.4%	10.57%
Operating Expenses	$87.80M	$99.14M	$27.86M
YoY Change	-11.44%	255.8%	20.04%
Operating Profit	$13.10M	$14.54M	$16.58M
YoY Change	-9.92%	-12.3%	96.6%
Interest Expense	-$6.600M	-$13.60M
YoY Change	-51.47%
% of Operating Profit	-50.38%	-93.52%
Other Income/Expense, Net	$7.900M	-$15.15M	-$221.0K
YoY Change	-152.15%	6754.75%	-87.05%
Pretax Income	-$1.300M	-$600.0K	$16.40M
YoY Change	116.67%	-103.66%	144.78%
Income Tax	-$6.700M	-$417.0K	$3.241M
% Of Pretax Income			19.76%
Net Earnings	$5.400M	-$190.0K	$13.12M
YoY Change	-2942.11%	-101.45%	122.17%
Net Earnings / Revenue	2.87%	-0.09%	17.31%
Basic Earnings Per Share		$0.00	$0.21
Diluted Earnings Per Share	$68.61K	$0.00	$0.21
COMMON SHARES
Basic Shares Outstanding	83.02M shares	71.08M shares	62.47M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q1	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$328.8M	$191.7M	$361.5M
YoY Change	71.52%	-46.97%	50.44%
Cash & Equivalents	$328.8M	$191.7M	$361.5M
Short-Term Investments			$0.00
Other Short-Term Assets	$58.61M	$34.71M	$7.534M
YoY Change	68.84%	360.72%	61.12%
Inventory
Prepaid Expenses
Receivables	$72.77M	$70.86M	$25.67M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$460.2M	$297.3M	$394.7M
YoY Change	54.79%	-24.67%	48.71%
LONG-TERM ASSETS
Property, Plant & Equipment	$29.11M	$33.49M	$8.223M
YoY Change	-13.08%	307.22%	4.94%
Goodwill	$1.327B	$1.333B	$4.651M
YoY Change	-0.41%	28552.57%	0.0%
Intangibles	$767.0M	$783.3M	$79.67M
YoY Change	-2.08%	883.2%	-4.75%
Long-Term Investments			$209.0K
YoY Change
Other Assets	$37.42M	$35.09M	$21.12M
YoY Change	6.64%	66.13%	17.17%
Total Long-Term Assets	$2.250B	$2.268B	$115.3M
YoY Change	-0.77%	1866.1%	11.16%
TOTAL ASSETS
Total Short-Term Assets	$460.2M	$297.3M	$394.7M
Total Long-Term Assets	$2.250B	$2.268B	$115.3M
Total Assets	$2.710B	$2.565B	$510.0M
YoY Change	5.67%	402.92%	38.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.614M	$3.980M	$3.520M
YoY Change	-59.45%	13.07%	45.45%
Accrued Expenses	$75.88M	$46.37M	$8.552M
YoY Change	63.63%	442.24%	54.9%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$62.50M	$39.06M	$0.00
YoY Change	60.0%
Total Short-Term Liabilities	$204.7M	$151.9M	$29.05M
YoY Change	34.73%	422.96%	41.79%
LONG-TERM LIABILITIES
Long-Term Debt	$924.2M	$1.182B	$0.00
YoY Change	-21.78%
Other Long-Term Liabilities	$8.808M	$2.625M	$2.968M
YoY Change	235.54%	-11.56%	23.92%
Total Long-Term Liabilities	$1.127B	$1.383B	$3.884M
YoY Change	-18.5%	35501.16%	62.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$204.7M	$151.9M	$29.05M
Total Long-Term Liabilities	$1.127B	$1.383B	$3.884M
Total Liabilities	$1.332B	$1.535B	$32.94M
YoY Change	-13.23%	4559.46%	43.92%
SHAREHOLDERS EQUITY
Retained Earnings	$220.3M	$211.5M	$171.9M
YoY Change	4.18%	23.08%	74.81%
Common Stock	$8.000K	$7.000K	$6.000K
YoY Change	14.29%	16.67%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.379B	$1.030B	$477.1M
YoY Change
Total Liabilities & Shareholders Equity	$2.710B	$2.565B	$510.0M
YoY Change	5.67%	402.92%	38.16%

Cashflow Statement

Concept	2021 Q1	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	$5.400M	-$190.0K	$13.12M
YoY Change	-2942.11%	-101.45%	122.17%
Depreciation, Depletion And Amortization	$30.40M	$26.60M	$4.700M
YoY Change	14.29%	465.96%	-4.08%
Cash From Operating Activities	$60.90M	$30.90M	$32.60M
YoY Change	97.09%	-5.21%	64.65%
INVESTING ACTIVITIES
Capital Expenditures	-$20.30M	-$10.60M	-$3.000M
YoY Change	91.51%	253.33%	-55.88%
Acquisitions
YoY Change
Other Investing Activities	$0.00	-$14.50M	$41.30M
YoY Change	-100.0%	-135.11%	-20750.0%
Cash From Investing Activities	-$20.30M	-$25.10M	$38.30M
YoY Change	-19.12%	-165.54%	-655.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.20M	11.30M	1.600M
YoY Change	-199.12%	606.25%	-30.43%
NET CHANGE
Cash From Operating Activities	60.90M	30.90M	32.60M
Cash From Investing Activities	-20.30M	-25.10M	38.30M
Cash From Financing Activities	-11.20M	11.30M	1.600M
Net Change In Cash	29.40M	17.10M	72.50M
YoY Change	71.93%	-76.41%	376.97%
FREE CASH FLOW
Cash From Operating Activities	$60.90M	$30.90M	$32.60M
Capital Expenditures	-$20.30M	-$10.60M	-$3.000M
Free Cash Flow	$81.20M	$41.50M	$35.60M
YoY Change	95.66%	16.57%	33.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001428336
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-01-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--01-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity File Number EntityFileNumber	001-36568
CY2021	dei	Entity Registrant Name EntityRegistrantName	HEALTHEQUITY, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	52-2383166
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	15 West Scenic Pointe Drive
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Draper
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	UT
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	84020
CY2021	dei	City Area Code CityAreaCode	801
CY2021	dei	Local Phone Number LocalPhoneNumber	727-1000
CY2021	dei	Security12b Title Security12bTitle	Common stock, par value $0.0001 per share
CY2021	dei	Trading Symbol TradingSymbol	HQY
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	70863000	USD
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2020Q3	dei	Entity Public Float EntityPublicFloat	3900000000	USD
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	83017352	shares
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	328803000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	191726000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4239000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1216000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	72767000	USD
CY2021Q1	us-gaap	Other Assets Current OtherAssetsCurrent	58607000	USD
CY2020Q1	us-gaap	Other Assets Current OtherAssetsCurrent	34711000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	460177000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	297300000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29106000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33486000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	89508000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	83178000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	767003000	USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	783279000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	1327193000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	1332631000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	0	USD
CY2020Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	18000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	37420000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35089000	USD
CY2021Q1	us-gaap	Assets Assets	2710407000	USD
CY2020Q1	us-gaap	Assets Assets	2564981000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1614000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3980000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	50670000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	50121000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	75880000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	46372000	USD
CY2021Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	62500000	USD
CY2020Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	39063000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14037000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12401000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	204701000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	151937000	USD
CY2021Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	924217000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1181615000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	74224000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	68017000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8808000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2625000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	119729000	USD
CY2020Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	130492000	USD
CY2021Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1126978000	USD
CY2020Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1382749000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	1331679000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	1534686000	USD
CY2021Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	100000000	shares
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	900000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	77168000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	77168000	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	71051000	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	71051000	shares
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	7000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1158372000	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	818774000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	220348000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	211514000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1378728000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	1030295000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2710407000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2564981000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	733570000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	531993000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	287243000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	318236000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	206084000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	106050000	USD
CY2021	us-gaap	Gross Profit GrossProfit	415334000	USD
CY2020	us-gaap	Gross Profit GrossProfit	325909000	USD
CY2019	us-gaap	Gross Profit GrossProfit	181193000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	84493000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	60561000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	33039000	USD
CY2021	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	76064000	USD
CY2020	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	34704000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	49964000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	43951000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	29498000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	124809000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	77576000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35057000	USD
CY2019	hqy	Amortization Of Acquired Intangible AmortizationOfAcquiredIntangible	5929000	USD
CY2021	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	45990000	USD
CY2020	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	32111000	USD
CY2019	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	0	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	381320000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	248903000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	103523000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	34014000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	77006000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	77670000	USD
CY2021	us-gaap	Interest Expense InterestExpense	34881000	USD
CY2020	us-gaap	Interest Expense InterestExpense	24772000	USD
CY2019	us-gaap	Interest Expense InterestExpense	270000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5007000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9079000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1582000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-29874000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-33851000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1852000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	4140000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	43155000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	75818000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4694000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3491000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1919000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8834000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	39664000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	73899000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.20
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.17
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74235000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67026000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61836000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75679000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	68453000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63370000	shares
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	346274000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22929000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	21057000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	73899000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	477079000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	11438000	USD
CY2020	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	462270000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	39844000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	39664000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	1030295000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9956000	USD
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	286780000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	42863000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8834000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1378728000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8834000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	39664000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	73899000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	115904000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	55352000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	18185000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	42863000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	39844000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	21057000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5102000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2711000	USD
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	60000	USD
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2020	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	27570000	USD
CY2019	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-103000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1753000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-728000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-676000	USD
CY2021	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-5132000	USD
CY2020	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	3665000	USD
CY2019	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	408000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	413000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4029000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4066000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	24839000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	12577000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	5799000	USD
CY2021	hqy	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-11150000	USD
CY2020	hqy	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	-6218000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	771000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4550000	USD
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	4432000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13093000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	30422000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1920000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3894000	USD
CY2021	hqy	Increase Decrease In Operating Lease Liability Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent	-10803000	USD
CY2020	hqy	Increase Decrease In Operating Lease Liability Noncurrent IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent	-5383000	USD
CY2021	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	6007000	USD
CY2020	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	-83000	USD
CY2019	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	573000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	181619000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	105010000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	113422000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7286000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3869000	USD
CY2021	us-gaap	Payments For Software PaymentsForSoftware	51500000	USD
CY2020	us-gaap	Payments For Software PaymentsForSoftware	25654000	USD
CY2019	us-gaap	Payments For Software PaymentsForSoftware	9978000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	32371000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	9134000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1195000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1644575000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	0	USD
CY2020	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	53845000	USD
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	728000	USD
CY2021	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2020	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2019	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	41422000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-96964000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1740494000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25652000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	286779000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	458495000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	30504000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	239063000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7813000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1250000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2021	hqy	Payments To Settle Client Held Funds PaymentsToSettleClientHeldFunds	3862000	USD
CY2020	hqy	Payments To Settle Client Held Funds PaymentsToSettleClientHeldFunds	215790000	USD
CY2019	hqy	Payments To Settle Client Held Funds PaymentsToSettleClientHeldFunds	0	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8568000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	11347000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	22929000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	52422000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1465735000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22929000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	137077000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-169749000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	162003000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191726000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	361475000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	199472000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	328803000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191726000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	361475000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	27686000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	21806000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	203000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-6022000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9277000	USD
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	587000	USD
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	160000	USD
CY2020	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	487000	USD
CY2019	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	37000	USD
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	1930000	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	1742000	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	200000	USD
CY2021	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	5438000	USD
CY2020	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	USD
CY2019	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	0	USD
CY2021	hqy	Exercise Of Stock Options Receivable ExerciseOfStockOptionsReceivable	1478000	USD
CY2020	hqy	Exercise Of Stock Options Receivable ExerciseOfStockOptionsReceivable	0	USD
CY2019	hqy	Exercise Of Stock Options Receivable ExerciseOfStockOptionsReceivable	0	USD
CY2021	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	USD
CY2020	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	3776000	USD
CY2019	us-gaap	Other Significant Noncash Transaction Value Of Consideration Given1 OtherSignificantNoncashTransactionValueOfConsiderationGiven1	0	USD
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management has made estimates for the allowance for doubtful accounts, capitalized software development costs, evaluating goodwill and long-lived assets for impairment, useful lives of property and equipment and intangible assets, accrued compensation, accrued liabilities, grant date fair value of stock options and performance restricted stock units and restricted stock awards, and income taxes. Actual results could differ from those estimates.</span></div>
CY2021	us-gaap	Net Income Loss NetIncomeLoss	8834000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	39664000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	73899000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74235000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67026000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61836000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	74235000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	67026000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	61836000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1444000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1427000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1534000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	75679000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	68453000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63370000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.59
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.20
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.58
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.17
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2400000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4200000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1200000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3400000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000000.0	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	200000	USD
CY2021Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	27500000	USD
CY2020Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	21800000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1900000	USD
CY2021	us-gaap	Lease Cost LeaseCost	14274000	USD
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	1500000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	60093000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	49243000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	30987000	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	15757000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29106000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33486000	USD
CY2021	us-gaap	Depreciation Depreciation	16000000.0	USD
CY2020	us-gaap	Depreciation Depreciation	8900000	USD
CY2019	us-gaap	Depreciation Depreciation	3500000	USD
CY2021Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4100000	USD
CY2020Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3700000	USD
CY2021	hqy	Contract With Customer Recognition Term ContractWithCustomerRecognitionTerm	P12M
CY2021	hqy	Contract With Customer Recognition Term Interchange Arrangement ContractWithCustomerRecognitionTermInterchangeArrangement	P10Y
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2000000.0	USD
CY2021	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1045000	USD
CY2021	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1045000	USD
CY2020	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	5905000	USD
CY2020	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	5905000	USD
CY2019	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	1946000	USD
CY2021	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	0	USD
CY2021	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	0	USD
CY2020	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	27760000	USD
CY2020	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	27760000	USD
CY2019	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-102000	USD
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1118000	USD
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1118000	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	40810000	USD
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	40810000	USD
CY2019	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	2121000	USD
CY2021	hqy	Other Nonoperating Income Expense Miscellaneous OtherNonoperatingIncomeExpenseMiscellaneous	5080000	USD
CY2020	hqy	Other Nonoperating Income Expense Miscellaneous OtherNonoperatingIncomeExpenseMiscellaneous	-1934000	USD
CY2019	hqy	Other Nonoperating Income Expense Miscellaneous OtherNonoperatingIncomeExpenseMiscellaneous	-1305000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5007000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-9079000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1582000	USD
CY2021	hqy	Lessee Operating Lease Number Of Extensions LesseeOperatingLeaseNumberOfExtensions	1	extension
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	16073000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	9059000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	5456000	USD
CY2021	us-gaap	Sublease Income SubleaseIncome	1799000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	750000	USD
CY2019	us-gaap	Sublease Income SubleaseIncome	0	USD
CY2020	us-gaap	Lease Cost LeaseCost	8309000	USD
CY2019	us-gaap	Lease Cost LeaseCost	5456000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y7D
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y4M28D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0432
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0435
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	107150000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	18889000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	88261000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14037000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	74224000	USD
CY2021Q1	hqy	Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount	63100000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	12941000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	6361000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	17480000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	34196000	USD
CY2021Q1	us-gaap	Other Commitment Due In Fifth Year OtherCommitmentDueInFifthYear	0	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	962752000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	879597000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	195749000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	98851000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	767003000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	780746000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	767003000	USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	783279000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	99900000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46500000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14700000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	103188000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	91824000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	75136000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	58283000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	48532000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	390040000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	767003000	USD
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	5400000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	62500000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	70313000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	101562000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	768750000	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	0	USD
CY2021Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	0	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	1003125000	USD
CY2021Q1	hqy	Interest On Long Term Debt To Be Paid Year One InterestOnLongTermDebtToBePaidYearOne	19639000	USD
CY2021Q1	hqy	Interest On Long Term Debt To Be Paid Year Two InterestOnLongTermDebtToBePaidYearTwo	18451000	USD
CY2021Q1	hqy	Interest On Long Term Debt To Be Paid Year Three InterestOnLongTermDebtToBePaidYearThree	16893000	USD
CY2021Q1	hqy	Interest On Long Term Debt To Be Paid Year Four InterestOnLongTermDebtToBePaidYearFour	8877000	USD
CY2021Q1	hqy	Interest On Long Term Debt To Be Paid Year Five InterestOnLongTermDebtToBePaidYearFive	0	USD
CY2021Q1	hqy	Interest On Long Term Debt To Be Paid After Year Five InterestOnLongTermDebtToBePaidAfterYearFive	0	USD
CY2021Q1	hqy	Interest On Long Term Debt To Be Paid InterestOnLongTermDebtToBePaid	63860000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	15809000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	18082000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	16094000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	16341000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	16683000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	87235000	USD
CY2021Q1	hqy	Lessee Operating Lease Liability To Be Paid Including Leases Not Yet Commenced LesseeOperatingLeaseLiabilityToBePaidIncludingLeasesNotYetCommenced	170244000	USD
CY2021Q1	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	21948000	USD
CY2021Q1	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	15645000	USD
CY2021Q1	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	1756000	USD
CY2021Q1	us-gaap	Other Commitment Due In Fourth Year OtherCommitmentDueInFourthYear	402000	USD
CY2021Q1	us-gaap	Other Commitment OtherCommitment	39751000	USD
CY2021Q1	us-gaap	Other Commitment Due After Fifth Year OtherCommitmentDueAfterFifthYear	0	USD
CY2021Q1	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	119896000	USD
CY2021Q1	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	122491000	USD
CY2021Q1	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	136305000	USD
CY2021Q1	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	794370000	USD
CY2021Q1	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	16683000	USD
CY2021Q1	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	87235000	USD
CY2021Q1	us-gaap	Contractual Obligation ContractualObligation	1276980000	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	1000000000.00	USD
CY2021Q1	us-gaap	Long Term Debt LongTermDebt	1000000000.00	USD
CY2021	hqy	Sublease Income To Be Received SubleaseIncomeToBeReceived	3700000	USD
CY2021Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	30000000.0	USD
CY2018Q3	hqy	Loss Contingency Number Of Lawsuits LossContingencyNumberOfLawsuits	2	lawsuit
CY2018Q2	hqy	Loss Contingency Number Of Lawsuits LossContingencyNumberOfLawsuits	2	lawsuit
CY2021	hqy	Number Of Executives NumberOfExecutives	2	executive
CY2021	hqy	Number Of Executives NumberOfExecutives	2	executive
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	181000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-448000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1095000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	258000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	274000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	416000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	439000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-174000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1511000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1630000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	3538000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1258000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3503000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	127000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-850000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-5133000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	3665000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	408000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4694000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3491000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1919000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	869000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	9063000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	15922000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-99000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	960000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1518000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	469000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	798000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	251000	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Tax Expense Benefit Employee Remuneration Payments Amount EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitEmployeeRemunerationPaymentsAmount	1186000	USD
CY2020	hqy	Effective Income Tax Rate Reconciliation Tax Expense Benefit Employee Remuneration Payments Amount EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitEmployeeRemunerationPaymentsAmount	2117000	USD
CY2019	hqy	Effective Income Tax Rate Reconciliation Tax Expense Benefit Employee Remuneration Payments Amount EffectiveIncomeTaxRateReconciliationTaxExpenseBenefitEmployeeRemunerationPaymentsAmount	160000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-2983000	USD
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-4815000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-14255000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2195000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2296000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	2252000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	511000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	491000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	450000	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Nondeductible Expense Acquisition Related Costs EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAcquisitionRelatedCosts	0	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	3032000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther	0	USD
CY2021	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0	USD
CY2020	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	5790000	USD
CY2019	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	0	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Reclassification Of Operating Lease Right Of Use Assets EffectiveIncomeTaxRateReconciliationReclassificationOfOperatingLeaseRightOfUseAssets	185000	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Change In Net Operating Losses EffectiveIncomeTaxRateReconciliationChangeInNetOperatingLosses	377000	USD
CY2020	hqy	Effective Income Tax Rate Reconciliation Change In Net Operating Losses EffectiveIncomeTaxRateReconciliationChangeInNetOperatingLosses	0	USD
CY2019	hqy	Effective Income Tax Rate Reconciliation Change In Net Operating Losses EffectiveIncomeTaxRateReconciliationChangeInNetOperatingLosses	0	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Changein Deferred Tax Rate EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017ChangeinDeferredTaxRate	-1814000	USD
CY2020	hqy	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Changein Deferred Tax Rate EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017ChangeinDeferredTaxRate	225000	USD
CY2019	hqy	Effective Income Tax Rate Reconciliation Tax Cutsand Jobs Actof2017 Changein Deferred Tax Rate EffectiveIncomeTaxRateReconciliationTaxCutsandJobsActof2017ChangeinDeferredTaxRate	0	USD
CY2021	hqy	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	1010000	USD
CY2020	hqy	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	332000	USD
CY2019	hqy	Effective Income Tax Rate Reconciliation Return To Provision Adjustments EffectiveIncomeTaxRateReconciliationReturnToProvisionAdjustments	19000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-145000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	93000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	10000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-45000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-55000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	134000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-4694000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3491000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1919000	USD
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-1.134
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.081
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.025
CY2021Q1	hqy	Deferred Tax Assets Operating Loss Carryforwards Noncurrent DeferredTaxAssetsOperatingLossCarryforwardsNoncurrent	1653000	USD
CY2020Q1	hqy	Deferred Tax Assets Operating Loss Carryforwards Noncurrent DeferredTaxAssetsOperatingLossCarryforwardsNoncurrent	1147000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	12600000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	10764000	USD
CY2021Q1	hqy	Deferred Tax Assets Tax Credit Carryforwards Research Noncurrent DeferredTaxAssetsTaxCreditCarryforwardsResearchNoncurrent	6274000	USD
CY2020Q1	hqy	Deferred Tax Assets Tax Credit Carryforwards Research Noncurrent DeferredTaxAssetsTaxCreditCarryforwardsResearchNoncurrent	4693000	USD
CY2021Q1	hqy	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	21813000	USD
CY2020Q1	hqy	Deferred Tax Assets Lease Liability DeferredTaxAssetsLeaseLiability	20232000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	10591000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	6854000	USD
CY2021Q1	hqy	Deferred Tax Assets Other Noncurrent DeferredTaxAssetsOtherNoncurrent	1755000	USD
CY2020Q1	hqy	Deferred Tax Assets Other Noncurrent DeferredTaxAssetsOtherNoncurrent	2154000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	54686000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	45844000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	104000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	203000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	54582000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	45641000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4946000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4875000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	134442000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	142673000	USD
CY2021Q1	hqy	Deferred Tax Liabilities Incremental Contract Costs DeferredTaxLiabilitiesIncrementalContractCosts	6385000	USD
CY2020Q1	hqy	Deferred Tax Liabilities Incremental Contract Costs DeferredTaxLiabilitiesIncrementalContractCosts	5474000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	22285000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	21068000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	6081000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	1831000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	172000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	194000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	174311000	USD
CY2020Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	176115000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	119729000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	130474000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	100000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	200000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10200000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9400000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	500000	USD
CY2021Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	9400000	USD
CY2020Q1	us-gaap	Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit	8600000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	800000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9370000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1693000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	6888000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	835000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	790000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10206000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9370000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	10206000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9370000	USD
CY2021Q1	hqy	Unrecognized Tax Benefits Amount Netted Against Deferred Tax Assets UnrecognizedTaxBenefitsAmountNettedAgainstDeferredTaxAssets	9574000	USD
CY2020Q1	hqy	Unrecognized Tax Benefits Amount Netted Against Deferred Tax Assets UnrecognizedTaxBenefitsAmountNettedAgainstDeferredTaxAssets	8914000	USD
CY2021Q1	hqy	Unrecognized Tax Benefit Net UnrecognizedTaxBenefitNet	632000	USD
CY2020Q1	hqy	Unrecognized Tax Benefit Net UnrecognizedTaxBenefitNet	456000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	200000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	100000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	800000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	600000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42863000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45424000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21057000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	42863000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	45424000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21057000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	23.68
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	25.97
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	26.40
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2040000	shares
CY2020Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	0.10
CY2020Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	82.39
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	30.35
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y10M24D
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	74009000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	16000	shares
CY2021	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Granted ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansGranted	66.06
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	66.06
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	372000	shares
CY2021	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised	0.10
CY2021	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised	59.63
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	27.04
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y7M6D
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	81764000	USD
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	26.73
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	10000	shares
CY2021	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitForfeited	25.45
CY2021	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Forfeited ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitForfeited	44.53
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	37.43
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1674000	shares
CY2021Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding	1.25
CY2021Q1	hqy	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding	82.39
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.46
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	87164000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1674000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	31.46
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	87164000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1447000	shares
CY2021	hqy	Self Insurance Maximum Coverage Per Incident SelfInsuranceMaximumCoveragePerIncident	250000	USD

Files In Submission

Name	View Source	Status
0001428336-21-000011-index-headers.html	Edgar Link	pending
0001428336-21-000011-index.html	Edgar Link	pending
0001428336-21-000011.txt	Edgar Link	pending
0001428336-21-000011-xbrl.zip	Edgar Link	pending
exhibit211.htm	Edgar Link	pending
exhibit2312021-1x31.htm	Edgar Link	pending
exhibit3112021-1x31ceo.htm	Edgar Link	pending
exhibit3122021-1x31cfo.htm	Edgar Link	pending
exhibit3212021-1x31ceo.htm	Edgar Link	pending
exhibit3222021-1x31cfo.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hqy-20210131.htm	Edgar Link	pending
hqy-20210131.xsd	Edgar Link	pending
hqy-20210131_cal.xml	Edgar Link	unprocessable
hqy-20210131_def.xml	Edgar Link	unprocessable
hqy-20210131_g1.jpg	Edgar Link	pending
hqy-20210131_htm.xml	Edgar Link	completed
hqy-20210131_lab.xml	Edgar Link	unprocessable
hqy-20210131_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HQY
HEALTHEQUITY, INC. Stock $hqy

2021 Q1 Form 10-K Financial Statement

#000142833621000011 Filed on March 31, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY HEALTHEQUITY, INC. Stock $hqy

2021 Q1 Form 10-K Financial Statement

#000142833621000011 Filed on March 31, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HQY
HEALTHEQUITY, INC. Stock $hqy